AlzBiomarker
Alzheimer's Disease vs Control: sAPPα (CSF)
Meta-analysis Results: Levels of sAPPα in the cerebrospinal fluid were equivalent between people with Alzheimer’s disease and controls (effect size 1.026, p = 0.55842). sAPPα is a secreted peptide produced from APP processing.

